Focal low dose-rate brachytherapy for low to intermediate risk prostate cancer: preliminary experience at an Australian institution

Elliot Anderson, Lloyd M. L. Smyth, Richard O’Sullivan, Andrew Ryan, Nathan Lawrentschuk, Jeremy Grummet, Andrew W. See